Anti-Histone H3 (citrulline R2) antibody [EPR17703]
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
5
(1 Review)
|
(14 Publications)
Rabbit Recombinant Monoclonal H3 citrulline R2 antibody. Suitable for IP, I-ELISA, WB, PepArr and reacts with Transfected cell lysate, Mouse, Human, Recombinant fragment - Human samples. Cited in 14 publications.
View Alternative Names
H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, H3C1, H3FC, HIST1H3C, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l, H3R2cit
- I-ELISA
Supplier Data
Indirect ELISA - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (AB176843)
ELISA analysis of Human Histone H3 (ci recombinant protein at 100 ng/ml with ab176843. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500 dilution was used as the secondary antibody.
- IP
Supplier Data
Immunoprecipitation - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (AB176843)
Histone H3 was immunoprecipitated from 0.35 mg HEK-293T (human embryonic kidney) transfected with PADI4 expression vector containing a GFP-tag treated with 10 mM calcium chloride and 10 ?M lonomycin for 4 hours, whole cell lysate 10 ug with ab176843 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab176843 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : HEK-293T (human embryonic kidney) transfected with PADI4 expression vector containing a GFP-tag treated with 10 mM calcium chloride and 10 ?M lonomycin for 4 hours, whole cell lysate 10 ug
Lane 2 : ab176843 IP in HEK-293T transfected with PADI4 expression vector containing a GFP-tag treated with 10 mM calcium chloride and 10 ?M lonomycin for 4 hours whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab176843 in HEK-293T transfected with PADI4 expression vector containing a GFP-tag treated with 10 mM calcium chloride and 10 ?M lonomycin for 4 hours whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 min
All lanes:
Immunoprecipitation - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (ab176843)
Predicted band size: 15 kDa
false
- WB
Supplier Data
Western blot - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (AB176843)
Blocking/Dilution buffer : 5% NFDM/TBST.
PADI4 catalyzes the citrullination of arginine residues of histone proteins.
All lanes:
Western blot - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (ab176843) at 1/500 dilution
Lane 1:
NIH/3T3 (Mouse embyro fibroblast cells) cells transfected with vector control
Lane 2:
NIH/3T3 (Mouse embyro fibroblast cells) cells transfected with PADI4
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 15 kDa
Observed band size: 15 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (AB176843)
Blocking/Dilution buffer : 5% NFDM/TBST.
PADI4 catalyzes the citrullination of arginine residues of histone proteins.
All lanes:
Western blot - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (ab176843) at 1/500 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma cell line) cells transfected with vector control
Lane 2:
MCF7 (Human breast adenocarcinoma cell line) cells transfected with PADI4
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 15 kDa
Observed band size: 15 kDa
false
Exposure time: 30s
- PepArr
Unknown
Peptide Array - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (AB176843)
ab176843 was tested in Peptide Array against 501 different modified and unmodified histone peptides; each peptide is printed on the array at six concentrations (each in triplicate).
Circle area represents affinity between the antibody and a peptide : all antigen-containing peptides are displayed as red circles, all other peptides as blue circles. The affinity is calculated as area under curve when antibody binding values are plotted against the corresponding peptide concentration. Each circle area is normalized to the peptide with the strongest affinity.
The complete dataset, including full list of all peptides and information on the position of each peptide in the diagram, is available under the Product Protocol section.
- WB
CiteAb
Western blot - Anti-Histone H3 (citrulline R2) antibody [EPR17703] (AB176843)
Histone H3 (citrulline R2) western blot using anti-Histone H3 (citrulline R2) antibody [EPR17703] ab176843. Publication image and figure legend from Zhou, Y., Chen, B., et al., 2017, Front Immunol, PubMed 28993780.
ab176843 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab176843 please see the product overview.
Citrullination of extracellular substrates by intact neutrophils or neutrophil-conditioned media. (A) Upper panel, anti-citrullinated fibrinogen immunoblot of the supernatant from the incubation of fibrinogen for the indicated times in the presence of human neutrophils (lanes 1–7). Lane 7, fibrinogen was omitted. Lane 8 only contained fibrinogen. Lane 9, fibrinogen and recombinant PAD4. Lane 10, neutrophil-conditioned media. Lane 11, neutrophil with 2 mM EGTA. Lower panel, Coomassie Brilliant blue staining as a loading control. The bands corresponding to the α, β, and γ chains of fibrinogen are indicated. Note that α-fibrinogen is rapidly degraded by neutrophil-associated proteases. (B) Control immunoblot with anti-GAPDH, an intracellular protein, to demonstrate that significant lysis of neutrophils occurs only after 4 h of incubation with Triton X at 37°C under the experimental conditions. (C) Upper panel, anti-citrullinated histone H3 immunoblot of the supernatant from the incubation of histone H3 for the indicated time periods in the presence of human neutrophils (lanes 1–7). Lane 7, histone was omitted. Lane 8 only contained histone H3. Lane 9 contained histone H3 and recombinant PAD4. Lane 10, neutrophil-conditioned media. Lane 11, neutrophil with 2 mM EGTA. Note that citrullinated histone H3 is also cleaved by neutrophil-associated protease(s) to generate a slightly smaller protein. Lower panel, anti-histone H3 immunoblot as a loading control. This antibody does not recognize the proteolytically cleaved H3. (D) A similar experiment performed in the presence of an MMP inhibitor, a protease inhibitor cocktail, or both, as indicated. Lower panel, Coomassie Brilliant blue staining as a loading control. All data are representative of five independent experiments with different donors.
false
Related conjugates and formulations (1)
-
Anti-Histone H3 (citrulline R2) antibody [EPR17703] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download peptideArrayWebsite|en
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5393 PubMed40562767
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular biology and evolution 39: PubMed34730808
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:716250 PubMed34737738
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:675315 PubMed34616390
2021
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 22:1107-1117 PubMed34385713
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell 184:3915-3935.e21 PubMed34174187
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of thrombosis and haemostasis : JTH 18:2732-2743 PubMed32654410
2020
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:8451 PubMed31186478
2019
Applications
Unspecified application
Species
Unspecified reactive species
Epigenetics & chromatin 12:21 PubMed30940194
2019
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 8:15228 PubMed30323221
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com